STOCK TITAN
  1. Home
  2. News
  3. Clinical Trials

Clinical Trials News LIVE

Step into the labs where medical history is made. Our clinical trial news feed brings you to the forefront of scientific discovery and its market implications.

Each trial result is a potential game-changer. Whether it's a Phase 3 triumph or an unexpected study termination, we've got you covered.

Don't just follow biotech trends – anticipate them. With our real-time clinical trial updates, you're positioned to react to scientific progress as it happens, potentially before the broader market catches on.

11

NEWS
TODAY
check them out

-

NEWS ENHANCED BY
RHEA-AI
Who is Rhea? Read More
NEWS BY EXCHANGE
NYSE Nasdaq OTC

Stock News Live Feed

Today's News - Full List
IMPACT
SENTIMENT
MURA : Nasdaq
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
clinical trial low float
IMPACT
SENTIMENT
PYNKF : OTC
Perimeter B-Series OCT with ImgAssist AI 2.0 Demonstrates Super-Superiority Compared to Standard-of-Care in Pivotal Clinical Trial
clinical trial AI penny stock
IMPACT
SENTIMENT
PYXS : Nasdaq
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
clinical trial
IMPACT
SENTIMENT
CC : NYSE
Two-Phase Immersion Cooling Can Unlock up to 40% Decreased Data Center Energy Use and a Sustainable Future
clinical trial
IMPACT
SENTIMENT
PBYI : Nasdaq
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
clinical trial
IMPACT
SENTIMENT
RNXT : Nasdaq
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
clinical trial penny stock
IMPACT
SENTIMENT
MDT : NYSE
Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM
clinical trial fda approval
IMPACT
SENTIMENT
PRFX : Nasdaq
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
clinical trial low float penny stock
IMPACT
SENTIMENT
ONVO : Nasdaq
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting
clinical trial low float penny stock
IMPACT
SENTIMENT
CLDX : Nasdaq
Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
clinical trial
IMPACT
SENTIMENT
BIVI : Nasdaq
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
conferences clinical trial covid-19 low float
IMPACT
SENTIMENT
ZVSA : Nasdaq
ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial
clinical trial low float penny stock
IMPACT
SENTIMENT
MIRA : Nasdaq
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
clinical trial low float penny stock
IMPACT
SENTIMENT
APTO : Nasdaq
Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
clinical trial low float penny stock
IMPACT
SENTIMENT
KTTA : Nasdaq KTTAW : Nasdaq
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
clinical trial low float
IMPACT
SENTIMENT
HROW : Nasdaq
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
clinical trial
IMPACT
SENTIMENT
NAMS : Nasdaq NAMSW : Nasdaq
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
clinical trial
IMPACT
SENTIMENT
GDTC : Nasdaq
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
clinical trial low float
IMPACT
SENTIMENT
SAGE : Nasdaq
Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease
clinical trial
IMPACT
SENTIMENT
ARGX : Nasdaq
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
clinical trial
IMPACT
SENTIMENT
SGMO : Nasdaq
Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
clinical trial fda approval penny stock
IMPACT
SENTIMENT
RGBP : OTC RGBPP : OTC
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™
clinical trial low float penny stock
IMPACT
SENTIMENT
VKTX : Nasdaq
Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
clinical trial
IMPACT
SENTIMENT
GOVX : Nasdaq GOVXW : Nasdaq
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
clinical trial covid-19 low float
IMPACT
SENTIMENT
NXTC : Nasdaq
Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta
clinical trial penny stock
IMPACT
SENTIMENT
LTRN : Nasdaq
Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
clinical trial low float
IMPACT
SENTIMENT
ALZN : Nasdaq
Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimer’s Transgenic Mice
clinical trial low float penny stock
IMPACT
SENTIMENT
PHIO : Nasdaq
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
clinical trial low float
IMPACT
SENTIMENT
MRK : NYSE
Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
clinical trial
IMPACT
SENTIMENT
NKGFF : OTC
NEVADA KING COMMENCES ITS PHASE III, 20,000 METRE REGIONAL DRILL PROGRAM AT ATLANTA
clinical trial penny stock
IMPACT
SENTIMENT
BIIB : Nasdaq
Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
clinical trial
IMPACT
SENTIMENT
VIR : Nasdaq
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
clinical trial
IMPACT
SENTIMENT
JNJ : NYSE
Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results
clinical trial
IMPACT
SENTIMENT
PTGX : Nasdaq
Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113), a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor in Plaque Psoriasis
clinical trial
IMPACT
SENTIMENT
VIR : Nasdaq
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency
clinical trial
IMPACT
SENTIMENT
GRAL : Nasdaq AZN : Nasdaq DSNKY : OTC
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
clinical trial
IMPACT
SENTIMENT
ACET : Nasdaq
Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
clinical trial penny stock
IMPACT
SENTIMENT
NKTR : Nasdaq
Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence
clinical trial penny stock
IMPACT
SENTIMENT
NAMS : Nasdaq NAMSW : Nasdaq
NewAmsterdam Pharma Presents Additional Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia at AHA Scientific Sessions 2024
clinical trial
IMPACT
SENTIMENT
SLN : Nasdaq
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
clinical trial
IMPACT
SENTIMENT
CRDL : Nasdaq
Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
clinical trial penny stock
IMPACT
SENTIMENT
RCKT : Nasdaq
Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference
clinical trial
IMPACT
SENTIMENT
FUNI : OTC
Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes
clinical trial penny stock
IMPACT
SENTIMENT
PYNKF : OTC
Perimeter Medical Imaging to Announce Topline Results from Pivotal Clinical Trial Evaluating B-Series OCT with ImgAssist AI in Breast-Conserving Surgeries on November 20th; Conference Call to Follow
conferences clinical trial AI penny stock
IMPACT
SENTIMENT
ALLO : Nasdaq
Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence
clinical trial
IMPACT
SENTIMENT
ANIX : Nasdaq
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
clinical trial
IMPACT
SENTIMENT
FATE : Nasdaq
Fate Therapeutics Presents 6-Month Follow-up Data on First Patient Treated in Phase 1 Autoimmunity Study with Fludarabine-free Conditioning and FT819 Off-the-shelf, 1XX CAR T-cell Product Candidate at ACR Convergence
clinical trial
IMPACT
SENTIMENT
CTNM : Nasdaq
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
clinical trial fda approval low float
IMPACT
SENTIMENT
THAR : Nasdaq
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
clinical trial low float high short
IMPACT
SENTIMENT
BHC : NYSE
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
conferences clinical trial
Today's News - Full List